CAPRICOR THERAPEUTICS INC Chart calendar Capricor Therapeutics Inc
7bfebc86ef56f124c858f58.dmx3BgVVSIa2bAXqL0EfYIPsjC7SlSZbTvtpNx7W6EM.Q0FBRVIeBuTRWVSMbHBIIeGr222_2E0QeYsZeifmnTUXAig2NTsZzdsETA~ec66a6fa96756ae8e9a02eb81b0d13e7
Upcoming events on Capricor Therapeutics Inc
Past events on Capricor Therapeutics Inc
| 2024-04-03 01:30 pm | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 2024-03-26 02:00 pm | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-06 11:45 am | MDA Clinical and Scientific Conference |
| 2024-02-29 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-29 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-14 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-14 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-25 01:00 pm | Business Update Call |
| 2023-10-10 | Cell & Gene Meeting on the Mesa Conference |
| 2023-10-06 03:30 pm | World Muscle Society International Congress |
| 2023-09-29 08:30 am | Business Update Call |
| 2023-08-07 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-07 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-30 11:45 am | Parent Project Muscular Dystrophy Conference |
| 2023-06-21 04:00 pm | Maxim Group Virtual Healthcare Conference |
| 2023-06-12 01:00 pm | Annual Gieneral Meeting |
| 2023-05-11 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-11 04:01 pm | Q1 2023 Earnings Release |
| 2023-03-18 | Muscular Dystrophy Association Clinical & Scientific Conference |
| 2023-03-15 04:30 pm | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,01 0,84 19.43% | 0,31 0,25 23.12% | 0,24 0,22 10.07% | 2,55 1,60 59.87% | 25,2 21,0 19.64% | 21,4 |
|
EBITDA Million USD | Released Forecast Spread | -7,73 -8,40 7.93% | 0,00 0,00 - | -20,9 -19,4 -7.93% | -29,2 -30,1 3.11% | -22,8 -30,4 25.03% | -29,8 |
|
EBIT Million USD | Released Forecast Spread | -7,73 -8,26 6.39% | -13,7 -13,5 -1.26% | -20,9 -19,2 -9.1% | -29,7 -30,2 1.56% | -23,9 -28,1 15.08% | -34,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,64 -8,17 6.5% | -13,7 -13,5 -1.25% | -20,0 -18,3 -9.24% | -29,0 -29,8 2.49% | -22,3 -26,6 16.21% | -33,4 |
|
Net income Million USD | Released Forecast Spread | -7,64 -8,17 6.5% | -13,7 -13,5 -1.25% | -20,0 -18,3 -9.24% | -29,0 -29,8 2.49% | -22,3 -26,6 16.2% | -33,4 |
|
EPS USD | Released Forecast Spread | -2,06 -1,97 -4.83% | -0,88 -0,88 0% | -0,87 -0,80 -8.75% | -1,18 -1,22 3.01% | -0,83 -1,04 20.19% | -0,97 |
| Announcement Date | 18/03/20 | 11/03/21 | 10/03/22 | 15/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,24 0,43 -45.22% | 0,00 0,00 - | 0,00 0,20 - | 1,59 0,14 1036.84% | 0,96 0,01 19098% | 2,99 0,50 497.34% | 3,92 1,60 144.84% | 6,19 3,17 95.44% | 12,1 7,95 52.05% | 9,70 | 4,41 | 4,72 | 9,70 | |
|
EBITDA Million USD | Released Forecast Spread | -6,38 -4,80 -32.91% | -7,32 -6,00 -22.03% | -6,48 -7,00 7.46% | -7,87 -8,50 7.36% | -7,95 -8,00 0.57% | -7,49 -8,60 12.88% | -0,76 -7,60 90.06% | -3,60 | -10,3 | -10,0 | -5,80 | |||
|
EBIT Million USD | Released Forecast Spread | -6,38 -4,43 -44.14% | -7,32 -7,07 -3.55% | -6,48 -7,85 17.49% | -8,07 -8,57 5.9% | -8,18 -9,27 11.7% | -7,75 -8,98 13.71% | -6,86 -9,33 26.41% | -1,06 4,31 -124.68% | -3,81 | -8,89 | -9,63 | -4,73 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,19 -4,46 -38.71% | -7,11 -7,07 -0.54% | -6,37 -7,47 14.67% | -7,72 -8,49 9.06% | -7,77 -8,39 7.46% | -7,37 -8,73 15.62% | -6,39 -9,15 30.12% | -0,76 -5,06 84.94% | -3,48 | -8,94 | -9,45 | -4,78 | ||
|
Net income Million USD | Released Forecast Spread | -6,19 -4,46 -38.71% | -7,11 -7,07 -0.54% | -6,37 -7,47 14.67% | -7,72 -8,49 9.06% | -7,77 -8,39 7.46% | -7,37 -8,73 15.62% | -6,39 -9,15 30.12% | -0,76 -5,06 84.94% | -3,48 | -8,94 | -9,45 | -4,78 | ||
|
EPS USD | Released Forecast Spread | -0,26 -0,19 -36.84% | -0,32 | -0,29 -0,26 -13.73% | -0,26 -0,31 15.22% | -0,31 -0,34 8.82% | -0,31 -0,32 3.13% | -0,29 -0,35 16.35% | -0,25 -0,30 17.58% | -0,02 -0,20 89.74% | -0,11 | -0,29 | -0,30 | -0,13 | |
| Announcement Date | 06/08/20 | 10/03/22 | 10/05/22 | 10/08/22 | 10/11/22 | 15/03/23 | 11/05/23 | 07/08/23 | 14/11/23 | 29/02/24 | - | - | - | - |
More events
Past sector events for Capricor Therapeutics Inc
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
